ArticleJournal of cardiovascular development and disease2025
Subclinical Atrial Fibrillation Prediction in Patients with CIED by a Novel Deep Learning Framework.
Article in Journal of cardiovascular development and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Brief Description of the Cellular Mechanisms Involved in Cardiac Chemical Hypoxia.Cardiovascular toxicology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSubclinical atrial fibrillation (SCAF), a key risk factor for cryptogenic stroke, is difficult to predict with current tools. This study aimed to develop a novel deep learning framework, ResKAN-Attention, using only routine clinical data to predict SCAF in patients with cardiac implantable electronic device (CIED).
methodsIn this retrospective study, the ResKAN-Attention model was developed using 27 routine parameters from 124 CIED patients without prior AF. This framework features a dual-path architecture combining a Kolmogorov-Arnold Network (KAN) with a traditional multilayer perceptron, fused via a cross-attention mechanism. The model's performance was evaluated against common baselines using five-fold cross-validation, while its decision-making process was assessed through interpretability analysis. A clinically applicable risk scoring system was subsequently derived via knowledge distillation.
resultsOver a 12-month follow-up period, SCAF occurred in 31.5% of patients (39/124). The ResKAN-Attention model significantly outperformed all baseline models, achieving a mean AUC of 0.837 in cross-validation and 0.788 in external validation. Interpretability analysis identified left atrial diameter (LAD), gender, lactate dehydrogenase, BMI, and hypertension as top predictors. The simplified risk score exhibited excellent predictive power (AUC 0.882), retaining 99.1% of the complex model's performance on the fifth fold validation set.
conclusionsThe ResKAN-Attention model demonstrated promising preliminary results for SCAF prediction with enhanced interpretability. The distilled risk score provided a potential method for early risk stratification in clinical settings, demonstrating that advanced artificial intelligence (AI) can effectively predict complex cardiovascular events using readily available data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.